Global Mesalazine Market Research Report 2022

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,900	118 Pages	QYResearch Group	August, 2022	QYR17349339

Best Price Guarantee
Price	from $2,900
Length	118 Pages
Publisher	QYResearch Group
Published Date	August, 2022
SKU	QYR17349339

Global Mesalazine Market Research Report 2022

Due to the COVID-19 pandemic, the global Mesalazine market size is estimated to be worth US$ 179.73 million in 2022 and is forecast to a readjusted size of US$ 223.48 million by 2028 with a CAGR of 3.70% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for 53.03% of the Mesalazine global market in 2021, is projected to value US$ 137.98 million by 2028, growing at a revised 6.02% CAGR from 2022 to 2028. While Tablets segment is altered to an 2.49% CAGR throughout this forecast period.

North America Mesalazine market size was US$ 18.67 million in 2021, while Europe was US$ 68.91 million. The proportion of the North America was 11.54% in 2021, while Europe’s percentage was 42.59%, and it is predicted that Europe market share will reach 40.76% in 2028, trailing a CAGR of 3.16% through the analysis period. As for the Asia, the notable markets are Japan and South Korea, CAGR is 2.64% and 2.85% respectively for the next 6-year period.

The global major manufacturers of Mesalazine include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, and Lasa Loboratory, etc. In terms of revenue, the global three largest players hold a 50.43% market share of Mesalazine in 2021.

This report focuses on Mesalazine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Mesalazine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, etc.

Global Mesalazine Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Global Mesalazine Market: Segment Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

PharmaZell

Syntese A/S

Cambrex Corporation

Divis Laboratories

Chemi SpA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Segment by Type

Purity ≥97%

Purity ≥98%

Purity ≥99%

Segment by Application

Tablets

Capsules

Pellet and Granule

Suppository

Enema

Others

Consumption by Region

North America

U.S.

Canada

Mexico

Asia-Pacific

China

Japan

South Korea

India

Australia

Southeast Asia

Others

Europe

Germany

France

U.K.

Italy

Russia

Others

South America

Brazil

Argentina

Others

Middle East and Africa

GCC Countries

Israel

Iran

South Africa

Others

1 Mesalazine Market Overview: 1.1 Product Overview And Scope Of Mesalazine; 1.2 Mesalazine Segment By Type; 1.2.1 Global Mesalazine Sales Growth Rate Comparison By Type (2022-2028); 1.2.2 Purity ≥97%; 1.2.3 Purity ≥98%; 1.2.4 Purity ≥99%; 1.3 Mesalazine Segment By Application; 1.3.1 Global Mesalazine Sales Comparison By Application (2022-2028); 1.3.2 Tablets; 1.3.3 Capsules; 1.3.4 Pellet And Granule; 1.3.5 Suppository; 1.3.6 Enema; 1.4 Global Mesalazine Market Size Estimates And Forecasts; 1.4.1 Global Mesalazine Revenue 2017-2028; 1.4.2 Global Mesalazine Sales 2017-2028; 1.4.3 Mesalazine Market Size By Region: 2017 Versus 2021 Versus 2028
2 Mesalazine Market Competition By Manufacturers: 2.1 Global Mesalazine Sales Market Share By Manufacturers (2017-2022); 2.2 Global Mesalazine Revenue Market Share By Manufacturers (2017-2022); 2.3 Global Mesalazine Average Price By Manufacturers (2017-2022); 2.4 Manufacturers Mesalazine Manufacturing Sites, Area Served, Product Type; 2.5 Mesalazine Market Competitive Situation And Trends; 2.5.1 Mesalazine Market Concentration Rate; 2.5.2 The Global 5 And 10 Largest Mesalazine Players Market Share By Revenue; 2.5.3 Global Mesalazine Market Share By Company Type (Tier 1, Tier 2, And Tier 3); 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mesalazine Retrospective Market Scenario By Region: 3.1 Global Mesalazine Retrospective Market Scenario In Sales By Region: 2017-2022; 3.2 Global Mesalazine Retrospective Market Scenario In Revenue By Region: 2017-2022; 3.3 North America Mesalazine Market Facts & Figures By Country; 3.3.1 North America Mesalazine Sales By Country; 3.3.2 North America Mesalazine Revenue By Country; 3.3.3 United States; 3.3.4 Canada; 3.3.5 Mexico; 3.4 Europe Mesalazine Market Facts & Figures By Country; 3.4.1 Europe Mesalazine Sales By Country; 3.4.2 Europe Mesalazine Revenue By Country; 3.4.3 Germany; 3.4.4 France; 3.4.5 U.K.; 3.4.6 Italy; 3.4.7 Russia; 3.5 Asia Pacific Mesalazine Market Facts & Figures By Region; 3.5.1 Asia Pacific Mesalazine Sales By Region; 3.5.2 Asia Pacific Mesalazine Revenue By Region; 3.5.3 China; 3.5.4 Japan; 3.5.5 South Korea; 3.5.6 India; 3.5.7 Australia; 3.5.8 Sea; 3.6 South America Mesalazine Market Facts & Figures By Country; 3.6.1 South America Mesalazine Sales By Country; 3.6.2 South America Mesalazine Revenue By Country; 3.6.3 Brazil; 3.6.4 Argentina; 3.7 Middle East And Africa Mesalazine Market Facts & Figures By Country; 3.7.1 Middle East And Africa Mesalazine Sales By Country; 3.7.2 Middle East And Africa Mesalazine Revenue By Country; 3.7.3 Gcc Countries; 3.7.4 Israel; 3.7.5 Iran; 3.7.6 South Africa
4 Mesalazine Historic Market Analysis By Type: 4.1 Global Mesalazine Sales Market Share By Type (2017-2022); 4.2 Global Mesalazine Revenue Market Share By Type (2017-2022); 4.3 Global Mesalazine Price By Type (2017-2022)
5 Mesalazine Historic Market Analysis By Application: 5.1 Global Mesalazine Sales Market Share By Application (2017-2022); 5.2 Global Mesalazine Revenue Market Share By Application (2017-2022); 5.3 Global Mesalazine Price By Application (2017-2022)
6 Key Companies Profiled: 6.1 Pharmazell; 6.1.1 Pharmazell Corporation Information; 6.1.2 Pharmazell Description And Business Overview; 6.1.3 Pharmazell Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.1.4 Pharmazell Mesalazine Product Portfolio; 6.2 Syntese A/S; 6.2.1 Syntese A/S Corporation Information; 6.2.2 Syntese A/S Description And Business Overview; 6.2.3 Syntese A/S Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.2.4 Syntese A/S Mesalazine Product Portfolio; 6.3 Cambrex Corporation; 6.3.1 Cambrex Corporation Corporation Information; 6.3.2 Cambrex Corporation Description And Business Overview; 6.3.3 Cambrex Corporation Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.3.4 Cambrex Corporation Mesalazine Product Portfolio; 6.4 Divis Laboratories; 6.4.1 Divis Laboratories Corporation Information; 6.4.2 Divis Laboratories Description And Business Overview; 6.4.3 Divis Laboratories Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.4.4 Divis Laboratories Mesalazine Product Portfolio; 6.5 Chemi Spa; 6.5.1 Chemi Spa Corporation Information; 6.5.2 Chemi Spa Description And Business Overview; 6.5.3 Chemi Spa Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.5.4 Chemi Spa Mesalazine Product Portfolio; 6.6 Ipca Laboratories; 6.6.1 Ipca Laboratories Corporation Information; 6.6.2 Ipca Laboratories Description And Business Overview; 6.6.3 Ipca Laboratories Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.6.4 Ipca Laboratories Mesalazine Product Portfolio; 6.7 Hangzhou Brother; 6.7.1 Hangzhou Brother Corporation Information; 6.7.2 Hangzhou Brother Description And Business Overview; 6.7.3 Hangzhou Brother Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.7.4 Hangzhou Brother Mesalazine Product Portfolio; 6.8 Lianyungang Fengheng Biopharm; 6.8.1 Lianyungang Fengheng Biopharm Corporation Information; 6.8.2 Lianyungang Fengheng Biopharm Description And Business Overview; 6.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio; 6.9 Lasa Loboratory; 6.9.1 Lasa Loboratory Corporation Information; 6.9.2 Lasa Loboratory Description And Business Overview; 6.9.3 Lasa Loboratory Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.9.4 Lasa Loboratory Mesalazine Product Portfolio; 6.10 Corden Pharma Bergamo; 6.10.1 Corden Pharma Bergamo Corporation Information; 6.10.2 Corden Pharma Bergamo Description And Business Overview; 6.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio; 6.11 Erregierre Spa; 6.11.1 Erregierre Spa Corporation Information; 6.11.2 Erregierre Spa Description And Business Overview; 6.11.3 Erregierre Spa Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.11.4 Erregierre Spa Mesalazine Product Portfolio; 6.12 Ctx Lifescience; 6.12.1 Ctx Lifescience Corporation Information; 6.12.2 Ctx Lifescience Description And Business Overview; 6.12.3 Ctx Lifescience Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.12.4 Ctx Lifescience Mesalazine Product Portfolio; 6.13 Ishita Active Pharma Ingredients; 6.13.1 Ishita Active Pharma Ingredients Corporation Information; 6.13.2 Ishita Active Pharma Ingredients Description And Business Overview; 6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio; 6.14 Yc Biotech (Jiangsu); 6.14.1 Yc Biotech (Jiangsu) Corporation Information; 6.14.2 Yc Biotech (Jiangsu) Description And Business Overview; 6.14.3 Yc Biotech (Jiangsu) Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.14.4 Yc Biotech (Jiangsu) Mesalazine Product Portfolio; 6.15 Xinxiang Tianfeng Fine Chemical; 6.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information; 6.15.2 Xinxiang Tianfeng Fine Chemical Description And Business Overview; 6.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue And Gross Margin (2017-2022); 6.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
7 Mesalazine Manufacturing Cost Analysis: 7.1 Mesalazine Key Raw Materials Analysis; 7.1.1 Key Raw Materials; 7.1.2 Key Suppliers Of Raw Materials; 7.2 Manufacturing Process Analysis Of Mesalazine; 7.3 Mesalazine Industrial Chain Analysis
8 Marketing Channel, Distributors And Customers: 8.1 Marketing Channel; 8.2 Mesalazine Distributors List; 8.3 Mesalazine Customers
9 Mesalazine Market Dynamics: 9.1 Mesalazine Industry Trends; 9.2 Mesalazine Market Drivers; 9.3 Mesalazine Market Challenges
10 Global Market Forecast: 10.1 Mesalazine Market Estimates And Projections By Type; 10.1.1 Global Forecasted Sales Of Mesalazine By Type (2023-2028); 10.1.2 Global Forecasted Revenue Of Mesalazine By Type (2023-2028); 10.2 Mesalazine Market Estimates And Projections By Application; 10.2.1 Global Forecasted Sales Of Mesalazine By Application (2023-2028); 10.2.2 Global Forecasted Revenue Of Mesalazine By Application (2023-2028); 10.3 Mesalazine Market Estimates And Projections By Region; 10.3.1 Global Forecasted Sales Of Mesalazine By Region (2023-2028); 10.3.2 Global Forecasted Revenue Of Mesalazine By Region (2023-2028)
11 Research Findings And Conclusion
12 Methodology And Data Source: 12.1 Methodology/Research Approach; 12.1.1 Research Programs/Design; 12.1.2 Market Size Estimation; 12.1.3 Market Breakdown And Data Triangulation; 12.2 Data Source; 12.2.1 Secondary Sources; 12.2.2 Primary Sources; 12.3 Author List; 12.4 Disclaimer
List Of Tables: Table 1. Global Mesalazine Sales Growth Rate Comparison By Type (2022-2028) & (Tons) & (Us$ Million); Table 2. Major Manufacturers Of Purity ≥97%; Table 3. Major Manufacturers Of Purity ≥98%; Table 4. Major Manufacturers Of Purity ≥99%; Table 5. Global Mesalazine Sales Growth Rate Comparison By Application (2022-2028) & (Tons) & (Us$ Million); Table 6. Global Mesalazine Market Size By Region (Us$ Million): 2017 Vs 2021 Vs 2028; Table 7. Global Mesalazine Market Competitive Situation By Manufacturers In 2021; Table 8. Global Mesalazine Sales (Tons) Of Key Manufacturers (2017-2022); Table 9. Global Mesalazine Sales Market Share By Manufacturers (2017-2022); Table 10. Global Mesalazine Revenue (Us$ Million) By Manufacturers (2017-2022); Table 11. Global Mesalazine Revenue Share By Manufacturers (2017-2022); Table 12. Global Market Mesalazine Average Price (Us$/Kg) Of Key Manufacturers (2017-2022); Table 13. Manufacturers Mesalazine Manufacturing Sites And Area Served; Table 14. Manufacturers Mesalazine Product Type; Table 15. Global Manufacturers Market Concentration Ratio (Cr5 And Hhi); Table 16. Global Mesalazine By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Mesalazine As Of 2021); Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans; Table 18. Global Mesalazine Sales By Region (2017-2022) & (Tons); Table 19. Global Mesalazine Sales Market Share By Region (2017-2022); Table 20. Global Mesalazine Revenue By Region (2017-2022) & (Us$ Million)